Back to top

ImmunityBio reports Q2 EPS (22c) vs. (10c) last year

Reports Q2 revenue $51.2M, consensus $49.7M. “Our record quarterly net product revenue of $50.7 million and eighth consecutive quarter of sequentia...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ImmunityBio, Inc. (IBRX)